Renal cell carcinoma (RCC)
|
|
- Winifred Skinner
- 5 years ago
- Views:
Transcription
1 Renal cell carcinoma (RCC) Introduction The most common solid renal tumor. Accounts for 2 3% of all adult malignancies. It is the 3 rd most common urological tumor in men and the 2 nd in women. It is th e 6 th most common tumor overall in men and the 10 th in women. Predominantly affects adult men (3/2) in the 6 th 7 th decade of life. The most lethal urological tumor. Higher incidence in African Americans. Etiology The only environmental risk factor accepted to date is tobacco exposure, which increases RR times. It has also been related to asbestos and cadmium exposure. Obesity, living in urban areas, and low socioeconomic status have also been associated with increased risk. Thought to be related to v itamins A and E since its incidence is higher in employees of laboratories where both substances are synthesized. First degree family history increases RR 2.9 fold. Other causal factors: end stage renal disease with acquired cystic disease, familial syn (tuberous sclerosis, VHL disease), and high blood dromes pressure. Pathology Conventional renal cell carcinoma (70 80%): has a worse prognosis than papillary or chromophobe variants. The most common genetic alteration in this type of tumor is 3p25 26 mutation (VHL gene). Includes the subtypes: clear, granular, and mixed cell carcinomas. Papillary carcinoma (10 15%): associated with ESRD and acquired cystic disease. Has a greater tendency to be multicentric. The most common genetic alteration is chromosome 7 and 17 trisomy and the loss of the Y chromosome. It originates in convoluted tubule cells (similar to conventional carcinoma). There are two types: - Type I (basophilic): basophilic cells with scant cytoplasm. - Type II (eosinophilic): eosinophilic cells with abundant granular cytoplasm (more aggressive). Chromophobe cell carcinoma (3 5%): derived from the cortical portion of the collecting tubule. It has an eosinophilic variant that accounts for 30% of this type. The most common genetic alteration is the loss of heterozygosity on chromosomes 1, 2, 6, 10, 13, 17, and 21, with a hypoploid conten t. Has a higher incidence of p53 mutations and expression of the oncogene c Kit. Has a better prognosis than conventional renal cell carcinoma. Bellini duct carcinoma (1%): originates in the medullary collecting duct. Occurs at a younger age (3 rd 5 th decade of life). The most frequent genetic abnormalities are deletions in chromosome 1 and monosomy in chromosomes 6, 8, 12, 18, 21, and the Y chromosome. Highgrade, aggressive tumors unresponsive to conventional therapy. Medullary carcinoma (<1%): associated exclusively with the sickle cell trait. It affects African Americans in the 3 rd decade of life. It originates in the calyceal epithelium close to the papillae. It is very aggressive, usually metastasized at the time of diagnosis, and unresponsive to conventional therapies. Sarcomatoid variant: described in all variants; not considered a subtype. Unclassified carcinoma (<3%): poorly differentiated tumor, very aggressive and unclassifiable.
2 Staging (Fig. 1) Robson classification: Stage Tumor localization I II Organ confined tumor Tumor extends into ipsilateral adrenal gland or perirenal fat, but not beyond Gerota s fascia IIIa Tumor extends into renal vein or inferior vena cava IIIb Regional lymph node metastasis IIIc Regional lymph node metastasis and vein extension (IIIa + IIIb) IVa Tumor extends beyond Gerota s fascia IVb Distant metastasis TNM classification: Primary tumor Regional Lymph nodes Distant metastasis Tx T0 T1 T1a T1b T2 pt2a pt2b T3 pt3a pt3b pt3c T4 Nx N0 N1 N2 M0 M1 TNM stage grouping Stage I T1N0M0 Stage II T2N0M0 Stage III Stag e IV The 2009 TNM staging classifi cation system Primary tumor cannot be assessed. No evidence of primary tumor. Tumor 7 cm in greatest dimension, limited to the kidney. Tumor 4 cm in greatest dimension, limited to the kidney. Tumor >4 cm but 7 cm in greatest dimension. Tumor >7 cm in greatest dimension, limited to the kidney. Tumor >7 cm but 10 cm in greatest dimension Tumor >10 cm limited to the kidney Tumor extends into major veins or perinephric tissues, but not into the ipsilateral adrenal gland and not beyond Gerota s fascia Tumor grossly extends into the renal vein or its segmental (musclecontaining) branches or tumor invades perirenal and/or renal sinus (peripelvic) fat, but not beyond Garota s fascia. Tumor grossly extends into the vena cava below the diaphragm. Tumor grossly extends into the vena cava above the diaphragm or invades the wall of the vena cava. Tumor invades beyond Gerota s fascia (including contiguous extension into the ipsilateral adrenal gland). Regional lymph nodes cannot be assessed. No regional lymph node metastasis. Metastasis in a single regional lymph node. Metastasis in more than 1 regional lymph node. No distant metastasis. Distant metastasis. T3N0 1M0, y T1 2N1M0 T4N0 2M0, T0 4N2M0 y T0 4N0 2 M1
3 s Fig 1. TNM classification (2009): primary tumor.
4 Symptoms Over 50% are diagnosed incidentally. If symptoms appear, they are due to tumor growth, metastatic disease, paraneoplastic syndrome (20%), o r bleeding. The classic triad (pa in, mass, and hematuria) is uncommon (<10%). The most common symptoms are: pain (34%), hematuria (57%), weight loss (31%), Wunderlich syndrome (50% of cases have a hidden tumor). Paraneoplastic syndrome (20%): - Hypercalcemia (13%): production of PTH like or osteolytic metastases. - Polycyt hemia (1 8%): increased EPO production. - Amyloidos is (1 5%). - Anemia (20 40%). - Cachexia and febrile syndrome (20 33%) due to the formation of immunoglobulins. - AHT (25%): secondary to increased renin production. - Liver dysfunction or Stauffer s syndrome (3 20%). - Nephropathy (27%). - Other less common syndromes: hyperglycemia, Cushing s syndrome, neuromyopathy. Diagnosis Elevated alkaline phosphatase, high ESR, and anemia in the analysis indicate a poor prognosis. Plain abdominal X ray t o detect: - A mass effect in large tumors. - Diaphragm elevation. - Calcifications. - Metastatic bone lesions. Chest X ray: useful in the diagnosis of lung disease. Ultrasound: - Usually shows a solid iso or hypoechoic lesion. - Sometimes tumors must be differentiated from simple cysts, characterized by a smooth wall, round or oval morphology, and without internal echoes; transmission through a cyst has strong acoustic shadows behind the hypoechoic area. - If the lesion is not a cyst, the next exam should be a CT or MRI. CT: the single most important radiological examination in a diagnostic assessment. 10% of renal masses are indeterminate and require further testing (MRI/exploratory surgery). Allows assessment of local and distant venous extension. The diagnostic criteria based on Hounsfield units is as follows: - Any mass that is reinforced by more than 15 HU with iv administration of iodinated contrast media is considered a renal carcinoma. - Negative attenuation values in the CT (< 20 HU) are indicative of an angiomyolipoma. MRI: detects smaller lesions than CT and more adequately differentiates between cysts and solid lesions. Can be reserved for cases of locally advanced disease, venous compromise, or allergy to iodinated contrast. The tumors appear as: - Heterogeneous hypo or hyperintense masses in T1. - Hyperintense in T2. PET: good specificity, but low sensitivity. Bone scan: allows assessment of bone involvement in the extension study. Renal arteriography: is currently of limited value. Ultrasound or CT guided needle biopsy: their sensitivity and specificity vary between 80 95% with low morbidity (<5%). Indicated in the following cases: - Suspected renal abscess. - Infected cys t. - Differential diagnosis between RCC, suspected metastatic disease, or renal lymphoma.
5 Prognostic factors Stage: the single most important prognostic factor as there is a strong prognostic correlation. Loco regional or s ystemic extension significantly lowers chances for survival: Tumor localization % sur v ival ( 5 years) Localized tumor Tumor extends into ipsilateral adrenal or perirenal fat Tumor extends into major veins <25 Tumor extends beyond Gerota s fascia <20 Distant metastasis <20 Fuhrman nuclear grade: independent prognostic factor of survival. Nuclear grade I Uniform nuclear margin, nuclear size <10mm, absent nucleolus II Irregular nuclear margins, nuclear size >15mm, small nucleolus III Irregular nuclear margins, nuclear size 20mm, prominent nucleolus IV Multilob ulated nucleus, nuclear size >20, chromatin bodies Histological subtype: sarcomatoid differentiation, Bellini s carcinoma, and medullary carcinoma have worse survival rates. DNA ploidy: mainly in organ confined tumors. Aneuploidy is significantly associated with a worse prognosis. Other prognostic factors: general malaise, symptomatic presentation, constitutional syndrome, and synchronous metastases are poor prognostic factors. The presence of anemia, elevated ESR, elevated alkaline phosphatase, and elevated LDH at the time of diagnosis are also signs of a poor prognosis. Treatment of organ confined tumors Active surveillance: - Indications: homogen ous tumors with well defined margins, <3 cm, and in elderly patients with high surgical risk. - Rate of tumor growth: cm/year (30% do not grow during follow up). - Monitoring with contrasted imaging techniques is recommended every 6 12 months. Nephron sparing surgery (open or laparoscopic): - Imperative in bilateral tumors or tumors in a single kidney patient. - Compromised renal function or systemic disease (AHT, DM) is considered a relative indication. - If there is a normal contralateral kidney, it is considered an elective indication. - Tumors up to 7 cm can be removed by means of this technique. - Complications: urinary fistula (3 8%) and bleeding (most common complication). - Efficacy: the 5 year disease free survival rate is %. - Local recurrence rate: 5 10%. Ablative therapies: cryosurgery and radiofrequency. - May be percutaneous or laparoscopic. - Indications: advanced age; significant comorbidity; solid, peripheral exophytic tumors <3.5 cm and far from the vascular and collecting systems. Also in recurrences after conservative surgery. - Recurrence: 5 15%. Short follow up techniques. Radical nephrectomy: indicated in cases in which conservative surgery is not possible. - Lymphadenectomy: controversial. Recommended in cases with ganglionary involvement or in palliative cytoreductive surgery. - Removal of the adrenal gland: in cases with macroscopic or radiological implications.
6 Treatment of locally advanced and metastatic tumors Radical nephrectomy with lymphadenectomy or adrenalectomy or thrombectomy. Cytoreductive nephrectomy: nephrectomy for metastatic RCC. Indicated in patients with good general health, little metastatic disease, and scant liver or bone involvement. Resection of metastasis: - Indicated in solitary lesions, pulmonary lesions, and patients who have been diseasefree for a long period (metachronic metastasis). - Contraindicat ed in multiple, liver or bone metastases; in synchronic tumors; or in patients who have been disease free for only a short time. Systemic therapy: - Chemotherapy: low response rate (2 6%) due to the expression of a P glycoprotein (mul in 80 90% of renal tumors. tidrug resistant protein) - Radiation therapy: only useful for symptomatic palliative treatment of bone metastases. - Immunological treatment: Cytokines: - Interferon α: overall response = 12% (1.8% complete response). Mean survival of 5 15 months. - IL 2: overall response = 15% (6 8% complete response). Mean survival of months. High toxicity when taken alone (Muscle weakness syndrome). - Com bination of both: overall response = 19%. Does not improve survival rates. Adoptive immunotherapy: transfer of autologous lymphocytes. Has shown no benefits over cytokine therapy. Vaccines: no clinical trials have proven their clinical usefulness. Target therapies: currently the first line of adjuvant treatment. All are aimed at dis the VEGF pathway: rupting - Bevacizumab: monoclonal Ab that binds to VEGF, inhibiting its signal. Does not improve survival, but increases time to progression. Not used in monotherapy. - Sunitinib: oral agent that inhibits the tyrosine kinase receptor. Improves survival and produces tumor regression in 30 40% of cases. - Sorafenib: oral agent that inhibits the kinase RAF receptor. Has been shown to improve the progression free rate, disease stabilization, and tumor regression. - Temsirolimus: intravenous agent that inhibits m TOR. Blocks HIF 1. Improves survival rates. - Everolimus: the most recent oral agent; used as a 2 nd line treatment. - Multimodal therapy: most cases are treated with more than one treatment modality: a combination of primary tumor surgery +/ metastasis surgery +/ systemic therapies.
GUIDELINES ON RENAL CELL CARCINOMA
GUIDELINES ON RENAL CELL CARCINOMA B. Ljungberg (chairman), D.C. Hanbury, M.A. Kuczyk, A.S. Merseburger, P.F.A. Mulders, J-J. Patard, I.C. Sinescu Introduction This EAU guideline was prepared to help urologists
More informationGuidelines on Renal Cell
Guidelines on Renal Cell Carcinoma (Text update March 2009) B. Ljungberg (Chairman), D.C. Hanbury, M.A. Kuczyk, A.S. Merseburger, P.F.A. Mulders, J-J. Patard, I.C. Sinescu Introduction Renal cell carcinoma
More informationGUIDELINES ON RENAL CELL CANCER
20 G. Mickisch (chairman), J. Carballido, S. Hellsten, H. Schulze, H. Mensink Eur Urol 2001;40(3):252-255 Introduction is characterised by a constant rise in incidence over the last 50 years, with a predominance
More informationRenal Parenchymal Neoplasms
Renal Parenchymal Neoplasms د. BENIGN TUMORS : Benign renal tumors include adenoma, oncocytoma, angiomyolipoma, leiomyoma, lipoma, hemangioma, and juxtaglomerular tumors. Renal Adenomas : The adenoma is
More information1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.
History and Physical Case Scenario 1 45 year old white male presents with complaints of nausea, weight loss, and back pain. A CT of the chest, abdomen and pelvis was done on 12/8/12 that revealed a 12
More informationSex: 女 Age: 51 Occupation: 無 Admission date:92/07/22
Sex: 女 Age: 51 Occupation: 無 Admission date:92/07/22 Chief complaint Unknown fever for one month Hand tremor and left huge renal tumor was noted Present illness Suffered from fever for one month, hand
More informationEAU GUIDELINES ON RENAL CELL CARCINOMA
EAU GUIDELINES ON RENAL ELL ARINOMA (Limited text update March 2016) B. Ljungberg (hair), K. Bensalah, A. Bex (Vice-chair), S. anfield, R.H. Giles (Patient Organisation Representative), M. Hora, M.A. Kuczyk,
More informationKidney Case 1 SURGICAL PATHOLOGY REPORT
Kidney Case 1 Surgical Pathology Report February 9, 2007 Clinical History: This 45 year old woman was found to have a left renal mass. CT urography with reconstruction revealed a 2 cm medial mass which
More informationMale genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital.
Male genital tract tumors Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital. adenocarcinoma Prostate Cancer most common male cancer in western countries more detected in
More informationManchester Cancer. Guidelines for the management of renal cancer
Guidelines for the management of renal cancer Approved by the urology pathway board September 2014 To be reviewed September 2016 Renal Cancer Guidelines 1. Introduction 1.1 Kidney cancer accounts for 3%
More informationGuidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer
Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group
More informationRole of imaging in RCC. Ultrasonography. Solid lesion. Cystic RCC. Solid RCC 31/08/60. From Diagnosis to Treatment: the Radiologist Perspective
Role of imaging in RCC From Diagnosis to Treatment: the Radiologist Perspective Diagnosis Staging Follow up Imaging modalities Limitations and pitfalls Duangkamon Prapruttam, MD Department of Therapeutic
More informationSection Activity Activity Description Details Reference(s)
Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with Renal Cell Carcinoma AA Cancer Centre Referrals Not routine pre-op referral indicated
More informationUrological Tumours 1 Kidney tumours 2 Bladder tumours
Urological Tumours 1 Kidney tumours 2 Bladder tumours Tim Bracey SpR Histopathology Derriford Hospital Kidney tumours What are we going to talk about?! Anatomy of urinary tract! Types of kidney tumours!
More informationRenal masses - the role of diagnostic imaging
Renal masses - the role of diagnostic imaging Poster No.: C-2471 Congress: ECR 2015 Type: Educational Exhibit Authors: V. Rai#; Bjelovar/HR Keywords: Cysts, Cancer, Structured reporting, Ultrasound, MR,
More informationThe new TNM staging for renal cell carcinoma: what and why the urologists want to know.
The new TNM staging for renal cell carcinoma: what and why the urologists want to know. Poster No.: C-1132 Congress: ECR 2011 Type: Educational Exhibit Authors: Y. Y. Lim, A. Hattab, A. Bradley ; Manchester/UK,
More informationPartial Nephrectomy Planning: Everybody s s doing it, you can to
Partial Nephrectomy Planning: Everybody s s doing it, you can to Brian R. Herts, MD Associate Professor of Radiology Head, Abdominal Imaging, Imaging Institute & Staff, The Glickman Urological and Kidney
More informationUICC TNM 8 th Edition Errata
UICC TNM 8 th Edition Errata ions are in italics Head and Neck Tumours Pages 20, p27, p34, p38, p41, and p49 ly pn2a Metastasis in a single ipsilateral lymph node, less than 3cm in greatest dimension with
More informationUICC TNM 8 th Edition Errata
UICC TNM 8 th Edition Errata ions are in italics Page 28 Oropharynx p16 positive Pathological Stage II,T2 N2 M0 T3 N0,N1 M0 Stage II,T2 N2 M0 T3,T4 N0,N1 M0 Page 61 Oesophagus Adenocarcinoma Pathological
More informationTumors of kidney and urinary bladder
Tumors of kidney and urinary bladder Overview of kidney tumors Benign and malignant Of the benign: papillary adenoma -cortical -small (0.5cm) -in 40% of population -clinically insignificant The most common
More informationNAACCR Webinar Series 1
NAACCR 2009 2010 Webinar Series Collecting Cancer Data: Kidney 1 Questions Please use the Q&A panel to submit your questions Send questions to All Panelist 2 Fabulous Prizes 3 NAACCR 2009 2010 Webinar
More informationMUSCLE - INVASIVE AND METASTATIC BLADDER CANCER
10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg
More informationAdvanced & Metastatic Renal Cell Carcinoma
Advanced & Metastatic Renal Cell Carcinoma An Update G. Renzulli January 2013 1 Overview of Cancers of the Kidney 2 Global Epidemiology 3 Global Epidemiology of Kidney Cancer 4 Globally, kidney cancer
More informationRENAL CELL CARCINOMA 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseud
GENITOURINARY PATHOLOGY Kathleen M. O Toole Toole, M.D. RENAL CELL CARCINOMA 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a
More informationRecommendations for cross-sectional imaging in cancer management, Second edition
www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Renal and adrenal tumours Faculty of Clinical Radiology www.rcr.ac.uk Contents Renal cell carcinoma 3 Clinical
More informationRenal tumors of adults
Renal tumors of adults Urinary Tract Tumors 2%-3% of all cancers in adults. The most common malignant tumor of the kidney is renal cell carcinoma. Tumors of the lower urinary tract are twice as common
More informationGUIDELINES FOR THE MANAGEMENT OF
GUIDELINES FOR THE MANAGEMENT OF RENAL CANCER Date of endorsement: July 2011 Authors: Mr. RD Mills & Mr. WH Turner Ref: AngCN-SSG-U3 Page 1 of 14 Approved and Published: Aug 2011 Title: Guidelines for
More informationBilateral Renal Angiomyolipomas with Invasion of the Renal Vein: A Case Report
Case Study TheScientificWorldJOURNAL (2008) 8, 145 148 TSW Urology ISSN 1537-744X; DOI 10.1100/tsw.2008.29 Bilateral Renal Angiomyolipomas with Invasion of the Renal Vein: A Case Report C. Blick, N. Ravindranath,
More informationSAMPLING OF POST NEPHRECTOMY CANCER CARE (5)
SAMPLING OF POST NEPHRECTOMY CANCER CARE (5) Universally recognized post-nephrectomy cancer treatment. Sampling: National Comprehensive Cancer Network (NCCN) NCCN Clinical Practice Guidelines in Oncology
More informationSolitary Contralateral Adrenal Metastases after Nephrectomy for Renal Cell Carcinoma
Original Report ISSN 1537-744X; DOI 10.1100/tsw.2004.39 Solitary Contralateral Adrenal after Nephrectomy for Renal Cell Carcinoma Nikolaos Antoniou, M.D. and Demetrios Karanastasis, M.D. General Hospital
More informationNCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Kidney Cancer. Version NCCN.org. Continue
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version 2.2016 NCCN.org NCCN Guidelines for Patients available at www.nccn.org/patients Continue Version 2.2016, 11/24/15 National Comprehensive
More informationThe Incidental Renal Mass in the Primary Care Setting
The Incidental Renal Mass in the Primary Care Setting Adele M. Caruso, MSN, CRNP Adult Nurse Practitioner The Perelman School of Medicine at the University of Pennsylvania Abstract There are approximately
More informationKidney. Protocol applies to all invasive carcinomas of renal tubular origin. It excludes Wilms tumors and tumors of urothelial origin.
Kidney Protocol applies to all invasive carcinomas of renal tubular origin. It excludes Wilms tumors and tumors of urothelial origin. Procedures Incisional Biopsy (Needle or Wedge) Partial Nephrectomy
More informationRenal cell cancer: overview and immunochemotherapy
1 Renal cell cancer: overview and immunochemotherapy Vincent Khoo Introduction and epidemiology Kidney cancer is a relatively common urological cancer, accounting for approximately 2% of all adult cancers.
More informationCase Scenario 1: Thyroid
Case Scenario 1: Thyroid History and Physical Patient is an otherwise healthy 80 year old female with the complaint of a neck mass first noticed two weeks ago. The mass has increased in size and is palpable.
More information2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule
GENITOURINARY PATHOLOGY Kathleen M. O Toole, M.D. Renal Cell Carcinoma 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow Necrotic Mass Grossly is a Bright
More informationComplex case Presentations
Complex case Presentations Case Presentations April 2016 Lisa M Pickering Case presentations: chromophobe renal carcinoma 60 year old man. ECOG PS 0 No significant comorbodities August 2009: L radical
More informationMUSCLE-INVASIVE AND METASTATIC BLADDER CANCER
MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER (Text update March 2008) A. Stenzl (chairman), N.C. Cowan, M. De Santis, G. Jakse, M. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, J.A. Witjes Introduction
More informationImaging characterization of renal clear cell carcinoma
Imaging characterization of renal clear cell carcinoma Poster No.: C-0327 Congress: ECR 2011 Type: Educational Exhibit Authors: S. Ballester 1, A. Gaser 2, M. Dotta 1, M. F. CAPPA 1, F. Hammar 1 ; 1 2
More informationKidney Cancer. NCCN Evidence Blocks. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version NCCN.org.
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) NCCN Evidence Blocks Version 2.2016 NCCN.org Continue Version 2.2016,12/07/15 National Comprehensive Cancer Network, Inc. 2015, All rights
More informationRenal Cancer. By Jamie Calderwood
Renal Cancer By Jamie Calderwood ("Kidney Cancer")*1 ("What are the different types of kidney mass?")*2 What is it? Renal cancer is more commonly known as kidney cancer. Wilms tumor Another name for kidney
More information4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey.
Management of Differentiated Thyroid Cancer: Head Neck Surgeon Perspective Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey Thyroid gland Small endocrine gland:
More informationPediatric Retroperitoneal Masses Radiologic-Pathologic Correlation
Acta Radiológica Portuguesa, Vol.XVIII, nº 70, pág. 61-70, Abr.-Jun., 2006 Pediatric Retroperitoneal Masses Radiologic-Pathologic Correlation Marilyn J. Siegel Mallinckrodt Institute of Radiology, Washington
More informationSt. Dominic s Annual Cancer Report Outcomes
St. Dominic s 2017 Annual Cancer Report Outcomes Cancer Program Practice Profile Reports (CP3R) St. Dominic s Cancer Committee monitors and ensures that patients treated at St. Dominic Hospital receive
More informationthe urinary system pathology Dr. Fairoz A Eltorgman
the urinary system pathology Dr. Fairoz A Eltorgman Tumors of the renal pelvis & kidney Benign tumors of the renal pelvis: Hemangioma Leiomyoma Malignant tumors: Transitional cell carcinoma Squamous cell
More informationCase Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors
CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior
More informationOral cancer: Prognosis & Treatment. Dr. Hani Al Sheikh Radhi
Oral cancer: Prognosis & Treatment Dr. Hani Al Sheikh Radhi Prognostic factors in Oral caner TNM staging T stage N stage M stage Site Histological Factors Vascular & Perineural Invasion Surgical Margins
More informationRCC in ADPKD / CKD / ESRD
RCC in ADPKD / CKD / ESRD FOIU 2018 David A. Goldfarb, MD,FACS Professor of Surgery, Cleveland Clinic Lerner College of Medicine Glickman Urological and Kidney Institute Cleveland Clinic, Cleveland, Ohio
More informationW J R. World Journal of Radiology. Review of renal cell carcinoma and its common subtypes in radiology. Abstract REVIEW
W J R World Journal of Radiology Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4329/wjr.v8.i5.484 World J Radiol 2016 May 28; 8(5): 484-500
More informationPrognostic factors in localized renal cell cancer
Original Article PROGNOSTIC FACTORS IN LOCALIZED RENAL CELL CANCER KNIGHT and STADLER Prognostic factors in localized renal cell cancer David A. Knight and Walter M. Stadler Section of Hematology/Oncology,
More informationRole Of Active Surveillance And Volume Monitoring In Patients With Small Renal Masses
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine January 2012 Role Of Active Surveillance And Volume Monitoring In
More information- RET/PTC rearrangement: 20% papillary thyroid cancer - RET: medullary thyroid cancer
Thyroid Cancer UpToDate: Introduction: Risk Factors: Biology: Symptoms: Diagnosis: 1. Lenvina is the first line therapy with powerful durable response and superior PFS in pts with RAI-refractory disease.
More informationThe International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements
Page 1 Contents 1.1. Registration... 2 1.2. Patient Characteristics... 3 1.3. Laboratory Values at Diagnosis... 5 1.4. Lung Cancers with Multiple Lesions... 6 1.5. Primary Tumour Description... 10 1.6.
More informationNCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Kidney Cancer. Version February 6, NCCN.org.
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version 3.2018 February 6, 2018 NCCN.org NCCN Guidelines for Patients available at www.nccn.org/patients Continue Version 3.2018, 02/06/18
More informationDIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES
DIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES Dr. Andrew J. Evans MD, PhD, FACP, FRCPC Consultant in Genitourinary Pathology University Health Network, Toronto, ON Case 1 43 year-old female,
More informationGenitourinary. Presentation Outline. Genitourinary System 12/14/2011. FCDS 2011 Educational Webcast Series December 15, 2011
Genitourinary FCDS 2011 Educational Webcast Series December 15, 2011 1 Susan Smith Pierce, CTR Gema Midence, MBA, CTR Steven Peace, BS, CTR Presentation Outline Overview including Anatomy and General Information
More information3. Guidelines for Reporting Bladder Cancer, Prostate Cancer and Renal Tumours
60 3. Guidelines for Reporting Bladder Cancer, Prostate Cancer and Renal Tumours Compilation and editing and of this volume: Prof. Chandu de Silva (Consultant Histopathologist) List of contributors Consultant
More informationHow To Approach Renal Masses? - Differential Diagnosis On Image
How To Approach Renal Masses? - Differential Diagnosis On Image Poster No.: C-1646 Congress: ECR 2015 Type: Educational Exhibit Authors: A. E. A. G. Costa, A. Gomes, A. Duarte, I. Távora; Lisbon/PT Keywords:
More informationRenal Mass Biopsy: Needed Now More than Ever
Renal Mass Biopsy: Needed Now More than Ever Stuart G. Silverman, MD, FACR Professor of Radiology Harvard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Boston,
More informationRenal Cell Carcinoma: Genetics & Imaging Srinivasa R Prasad University of Texas San Antonio
Renal Cell Carcinoma: Genetics & Imaging Srinivasa R Prasad University of Texas HSC @ San Antonio No financial disclosures Acknowledgements Dr. Peter Choyke, NIH My Gurus @ MIR, MGH 2004 WHO Taxonomy of
More informationRecruiting Active; not recruiting Completed Suspended Terminated. The biological sex of the patient. Female Unknown
Clinical Data Form Kidney Carcinoma Clinical Trial Sequencing Project Page 1 The Clinical Data Form (CDF) should be completed for every case. This form can be completed at the time the samples are submitted,
More informationImaging of Kidney Cancer
119 Imaging of Kidney Cancer RADIOLOGIC CLINICS OF NORTH AMERICA Radiol Clin N Am 45 (2007) 119 147 Jingbo Zhang, MD*, Robert A. Lefkowitz, MD, Ariadne Bach, MD - Detection and diagnosis - CT scan Solid
More informationTHORACIC MALIGNANCIES
THORACIC MALIGNANCIES Summary for Malignant Malignancies. Lung Ca 1 Lung Cancer Non-Small Cell Lung Cancer Diagnostic Evaluation for Non-Small Lung Cancer 1. History and Physical examination. 2. CBCDE,
More informationSurgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus
CONSENSUS STATEMENT Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus Ricardo A. Rendon, MD, FRCSC; * Anil Kapoor, MD, FRCSC; Rodney Breau, MD, FRCSC; Michael Leveridge,
More informationCanadian Urological Association guidelines for followup of patients after treatment of nonmetastatic
Canadian Urological Association guidelines for followup of patients after treatment of nonmetastatic renal cell carcinoma Wassim Kassouf, Leonardo L. Monteiro, Darrel E. Drachenberg, Adrian S. Fairey,
More informationRenal cancer in adults
Renal cancer in adults Diagnosis, treatment and follow-up NADIA BENAHMED, JO ROBAYS, SABINE STORDEUR, THIERRY GIL, STEVEN JONIAU, NICOLAAS LUMEN, LAURETTE RENARD, SANDRINE RORIVE, DIRK SCHRIJVERS, BERTRAND
More informationDiseases of the breast (2 of 2) Breast cancer
Diseases of the breast (2 of 2) Breast cancer Epidemiology & etiology The most common type of cancer & the 2 nd most common cause of cancer death in women 1 of 8 women in USA Affects 7% of women Peak at
More informationProposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram
Proposed All Wales Vulval Cancer Guidelines Dr Amanda Tristram Previous FIGO staging FIGO Stage Features TNM Ia Lesion confined to vulva with
More informationPre-operative Ultrasound of Lymph Nodes in Thyroid Cancer
Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer AACE - Advances in Medical and Surgical Management of Thyroid Cancer - 2018 Robert A. Levine, MD, FACE, ECNU Thyroid Center of New Hampshire Geisel
More informationUMEÅ UNIVERSITY MEDICAL DISSERTATIONS New Series No ISSN ISBN
UMEÅ UNIVERSITY MEDICAL DISSERTATIONS New Series No. 1138 ISSN 0346-6612 ISBN 978-91-7264-439-7 Departments of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden
More informationThe Incidental Renal lesion
The Incidental Renal lesion BACKGROUND Increase in abdominal CT/US in last 15 years Resulted in detection of many (small) renal lesions 50% > 50yrs has at least 1 lesion majority simple cysts Renal lesions
More informationThyroid and Adrenal Gland
Thyroid and Adrenal Gland NAACCR 2011 2012 Webinar Series 12/1/11 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
More informationVulvar Carcinoma. Definition: Cases should be classified as carsinoma of the vulva when the primary site growth is in the vulva Malignant melanoma sho
Carcinoma Vulva & Vagina Subdivisi Onkologi Ginekologi Bagian Obgin FK USU Vulvar Carcinoma. Definition: Cases should be classified as carsinoma of the vulva when the primary site growth is in the vulva
More informationVarious hereditary, acquired and neoplastic conditions can lead to cyst formation in the kidney.
Dr. Fatima AlAl-Hashimi Hashimi,, MD, FRCPath Salmaniya Medical Complex, Bahrain Various hereditary, acquired and neoplastic conditions can lead to cyst formation in the kidney. The most frequently encountered
More informationTreatment of oligometastatic NSCLC
Treatment of oligometastatic NSCLC Jarosław Kużdżał Department of Thoracic Surgery Jagiellonian University Collegium Medicum, John Paul II Hospital, Cracow New idea? 14 NSCLC patients with solitary extrathoracic
More informationUltrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer
Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer Its Not Just About the Nodes AACE Advances in Medical and Surgical Management of Thyroid Cancer - 2017 Robert A. Levine, MD,
More informationPrognostic factors of genitourinary tumors: Do we have to care?
Prognostic factors of genitourinary tumors: Do we have to care? Jae Y. Ro, MD, PhD Professor and Director of Surgical Pathology The Methodist Hospital, Weill Medical College of Cornell University, Houston,
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health Technology Appraisal
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health Technology Appraisal Cabozantinib for untreated locally advanced or metastatic renal cell carcinoma Final scope Remit/appraisal objective To appraise
More informationThyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose.
Thyroid Nodule Evaluating the patient with a thyroid nodule and some management options. Miguel V. Valdez PA C Disclosure Nothing to disclose. Learning Objectives Examination of thyroid gland Options for
More informationMultidisciplinary approach for renal cell carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute
Multidisciplinary approach for renal cell carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute 20 April, Antalya, Turkey RCC European Union 60.000 new diagnoses/year 26.000 Cancer related deaths
More informationMedical Management of Renal Cell Carcinoma
Medical Management of Renal Cell Carcinoma Lin Mei, MD Hematology-Oncology Fellow Hematology, Oncology and Palliative Care Virginia Commonwealth University Educational Objectives Background of RCC (epidemiology,
More informationPrognostic Factors and Staging Systems for Renal Cell Carcinoma
european urology supplements 6 (2007) 623 629 available at www.sciencedirect.com journal homepage: www.europeanurology.com Prognostic Factors and Staging Systems for Renal Cell Carcinoma Vincenzo Ficarra
More informationSurgically Discovered Xanthogranulomatous Pyelonephritis Invading Inferior Vena Cava with Coexisting Renal Cell Carcinoma
Case Study TheScientificWorldJOURNAL (2009) 9, 5 9 TSW Urology ISSN 1537-744X; DOI 10.1100/tsw.2009.6 Surgically Discovered Xanthogranulomatous Pyelonephritis Invading Inferior Vena Cava with Coexisting
More informationWilms Tumor and Neuroblastoma
Wilms Tumor and Neuroblastoma Wilm s Tumor AKA: Nephroblastoma the most common intra-abdominal cancer in children. peak incidence is 2 to 3 years of age Biology somatic mutations restricted to tumor tissue
More informationRENAL CELL CARCINOMA. About Renal cell carcinoma
RENAL CELL CARCINOMA Rcc, Grawitz Tumor A kidney cancer that originates in a part of the very small tubes in the kidney that transport waste molecules from the blood to the urine. Diagnosis Male & Female
More informationEAU Guidelines on Renal Cell Carcinoma
EAU Guidelines on Renal Cell Carcinoma B. Ljungberg (Chair), L. Albiges, K. Bensalah, A. Bex (Vice-chair), R.H. Giles (Patient Advocate), M. Hora, M.A. Kuczyk, T. Lam, L. Marconi, A.S. Merseburger, T.
More informationRENAL CANCER GUIDELINES
Greater Manchester and Cheshire Cancer Network RENAL CANCER GUIDELINES Agreed by Urology CSG: July 2010 Review Date: July 2012 Renal Cancer Guidelines 1. Introduction 1.1 Kidney cancer accounts for 3%
More informationRenal Masses in Patients with Known Extrarenal Primary Primary Cancer Primary Primary n Met Mets s RCC Beni L mphoma Lung Breast Others
The Importance of Stuart G. Silverman, MD, FACR Professor of Radiology Harvard ard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Boston, MA The Importance of
More informationCase Scenario year-old white male presented to personal physician with dyspepsia with reflux.
Case Scenario 1 57-year-old white male presented to personal physician with dyspepsia with reflux. 7/12 EGD: In the gastroesophageal junction we found an exophytic tumor. The tumor occupies approximately
More informationBREAST PATHOLOGY. Fibrocystic Changes
BREAST PATHOLOGY Lesions of the breast are very common, and they present as palpable, sometimes painful, nodules or masses. Most of these lesions are benign. Breast cancer is the 2 nd most common cause
More informationSmall Renal Mass Guidelines. Clif Vestal, MD USMD Arlington, Texas
Small Renal Mass Guidelines Clif Vestal, MD USMD Arlington, Texas Evaluation/Diagnosis 1. Obtain high quality, multiphase, cross-sectional abdominal imaging to optimally characterize/stage the renal mass.
More informationRenal Tumors in Adult Saudi Patients: A Review of 43 Cases
Riyadh F. Talic, FRCS(Ed); Salah R. El Faqih, FRCS From the Division of Urology, Department of Surgery, King Khalid University Hospital, King Saud University, Riyadh. Address reprint requests and correspondence
More informationA schematic of the rectal probe in contact with the prostate is show in this diagram.
Hello. My name is William Osai. I am a nurse practitioner in the GU Medical Oncology Department at The University of Texas MD Anderson Cancer Center in Houston. Today s presentation is Part 2 of the Overview
More informationSustained Response to Temsirolimus in Chromophobe variant of Metastatic Renal Cell Carcinoma
JOURNAL OF CASE REPORTS 2015;5(1):280-284 Sustained Response to Temsirolimus in Chromophobe variant of Metastatic Renal Cell Carcinoma Chanchal Goswami, Aditi Mandal B. P. Poddar Hospital & Medical Research
More informationBreast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined
Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women Mortality rates though have declined 1 in 8 women will develop breast cancer Breast Cancer Breast cancer increases
More informationRenal Cystic Disease. Dr H Bierman
Renal Cystic Disease Dr H Bierman Objectives Be able to diagnose renal cystic disease Genetic / non-genetic Be able to describe patterns of various renal cystic disease on routine imaging studies Be able
More informationUnusalPresentationofMetastasisfromaRenalCellCarcinoma-A CaseReportwithReviewofLiterature
Global Journal of Medical Research: K Interdisciplinary Volume 18 Issue 8 Version 1.0 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Online ISSN: 2249-4618 &
More information11/21/13 CEA: 1.7 WNL
Case Scenario 1 A 70 year-old white male presented to his primary care physician with a recent history of rectal bleeding. He was referred for imaging and a colonoscopy and was found to have adenocarcinoma.
More information